CryoPort Inc
Chiusa
SettoreTop Industriali
15.52 1.9
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
15.44
Massimo
15.65
Entrata | 65K -9.4M |
|---|---|
Vendite | 1.2M 49M |
EPS | -0.2 |
Margine di Profitto | -19.128 |
Dipendenti | 684 |
EBITDA | 1.8M -643K |
Utili prossimi | 3 nov 2026 |
|---|
Capitalizzazione di Mercato | 20M 801M |
|---|---|
Apertura precedente | 13.62 |
Chiusura precedente | 15.52 |
Notizie sul Sentiment di mercato
By Acuity
40%
60%
134 / 404 Classifica in Industrials
CryoPort Inc Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Notizie correlate
Confronto tra pari
Modifica del prezzo
CryoPort Inc Previsione
Sentiment
By Acuity
134 / 404 Classifica in Top Industriali
Notizie sul Sentiment di mercato
Prove rialziste
Volatilità
Sotto la media
Volume delle notizie (RCV)
Sotto la media
Notizie finanziarie
Spese di vendita e di amministrazione
Spese operative
Utile prima delle imposte
Vendite
Costo delle vendite
Utile lordo sulle vendite
Interessi passivi sul debito
EBITDA
Utile operativo
$
Chi Siamo CryoPort Inc
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
